We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ARGNF market cap is 34.95B. The company's latest EPS is USD -5.3192 and P/E is -113.66.
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 94.03M | 64.91M | 539.42M | 445.27M | 1.27B |
Operating Income | -198.89M | -477.62M | -348.75M | -720.34M | -425.05M |
Net Income | -181.21M | -608.46M | -408.27M | -709.59M | -295.05M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 1.61B | 2.28B | 2.85B | 3.13B | 4.54B |
Total Liabilities | 429.81M | 605.36M | 316.05M | 320.56M | 444.95M |
Total Equity | 1.18B | 1.67B | 2.53B | 2.81B | 4.1B |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 151.63M | -398.46M | -606.81M | -862.81M | -420.33M |
Investing | -833.27M | 344.69M | -347.07M | -461.18M | 308.21M |
Financing | 733.73M | 833M | 1.12B | 843.76M | 1.34B |
Market Cap | 34.95B |
Price to Earnings Ratio | -113.66 |
Price to Sales Ratio | 26.44 |
Price to Cash Ratio | 16.37 |
Price to Book Ratio | 8.18 |
Dividend Yield | - |
Shares Outstanding | 55.47M |
Average Volume (1 week) | 70 |
Average Volume (1 Month) | 70 |
52 Week Change | 74.07% |
52 Week High | 630.00 |
52 Week Low | 361.93 |
Spread (Intraday) | 19.62k (96.87%) |
Company Name | Argen X NV (PK) |
Address |
laarderhoogtweg 25 amsterdam, north holland 1101 EB |
Website | https://www.argenx.com |
Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions